News
Meningococcal serogroup C conjugate (MCC) vaccines are safe and effective. In England and Wales, MCC vaccine programs resulted in substantial herd immunity, as shown by reductions in serogroup C ...
A conjugate meningococcal vaccine (Menactra) was licensed in the U.S. in January 2005 and is recommended for all 11- and 12-year-olds, students entering high school, and college freshmen dormitory ...
3d
Zacks Investment Research on MSNGSK's Pentavalent Meningococcal Jab Recommended for Use by ACIPGSK plc GSK announced that the U.S. Centers for Disease Control and Prevention’s (“CDC”) Advisory Committee on Immunization ...
GSK’s 5-in-1 meningococcal vaccine Penmenvy receives positive recommendation from US Advisory Committee on Immunization Practices: London, UK Saturday, April 19, 2025, 13:00 Hrs ...
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
The meningococcal conjugate, or MenACWY vaccine (often called by brand names such as Menactra, Menveo, and MenQuadfi) features a vaccine that targets four of the most common types of bacterial ...
meningitidis. Multiple types of meningococcal vaccines protect against different serogroups of N. meningitidis. A serogroup includes multiple subspecies of the bacterium that share certain ...
the 13-valent pneumococcal conjugate vaccine, the quadrivalent meningococcal conjugate vaccine, as well as mRNA-based respiratory syncytial virus (RSV) and shingles vaccines, is anticipated in the ...
4d
MedPage Today on MSNACIP Endorses RSV Vaccine for At-Risk Adults 50 and UpThe CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...
Pentavalent vaccines can reduce the number of injections required to help protect against invasive meningococcal disease – especially disease caused by serogroup B. Their use could improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results